Clinical trial
Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition
NCT06132269 is registered in ClinicalTrials.gov with TCI Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation the Effect of AKK Formula on Intestinal Microbiota Regulation and Body Composition
- Lead sponsor
- TCI Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 9, 2023
- Completion date
- May 1, 2024
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.